Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors

ConclusionIrAEs, especially in skin, endocrine organ or gastrointestinal tract, triggered by ICIs indicate significant survival benefits.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research